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Abstract Alzheimer’s disease (AD) and Parkinson’s disease (PD) are two common,
progressive neurodegenerative brain disorders. Their diagnosis is very challenging
at an early disease stage, if based on clinical symptoms only. Brain imaging tech-
niques such as [18F]-fluoro-deoxyglucose positron emission tomography (FDG-
PET) can provide important additional information with respect to changes in the
cerebral glucose metabolism. In this study, we use machine learning techniques to
perform an automated classification of FDG-PET data. The approach is based on
the extraction of features by applying the scaled subprofile model with principal
component analysis (SSM/PCA) in order to extract characteristics patterns of glu-
cose metabolism. These features are then used for discriminating healthy controls,
PD and AD patients by means of two machine learning frameworks: Generalized
Matrix Learning Vector Quantization (GMLVQ) with local and global relevance
matrices, and Support Vector Machines (SVMs) with a linear kernel. Datasets from
different neuroimaging centers are considered. Results obtained for the individual
centers, show that reliable classification is possible. We demonstrate, however, that
cross-center classification can be problematic due to potential center-specific char-
acteristics of the available FDG-PET data.
Keywords. Machine Learning, Learning Vector Quantization, Neuroimaging,
Neurodegenerative Disorders, Alzheimer Disease, Parkinson Disease
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1. Introduction
Alzheimers disease (AD) and Parkinsons disease (PD) are the two most common neu-
rodegenerative brain diseases [1,2]. AD, with an average duration of 2 to 10 years, is
a type of dementia that affects over 7 million people in Europe [3], causing problems
with memory, thinking and behaviour. On the other hand, PD is manifested clinically
by bradykinesia (slowness of movement), muscular rigidity (stiffness), rest tremor and
postural instability (balance difficulties). It affects over 4 million people and over 80%
of patients with PD will eventually develop dementia (PDD) [4].
Differentiating between neurodegenerative brain disorders and their diagnosis at an
early disease stage can be challenging on clinical grounds only, as they have overlapping
clinical and pathological features at presentation. A thorough clinical evaluation com-
bined with imaging techniques, able to provide patterns of neuronal dysfunction which
are specific to a particular disease, might become an indispensable approach to assist the
accurate diagnosis and choice of appropriate treatment [5].
Technological advances have allowed for the acquisition of high-quality, three-
dimensional brain image data, which require the development of computer-aided algo-
rithms for efficient analysis. Earlier studies of image-based diagnoses of neurodegen-
rative diseases include the use of other technical platforms, see for instance [6,7,8]. In
this work we focus on the analysis of image data obtained by [18F]-fluoro-deoxyglucose
positron emission tomography (FDG-PET). We study the use of machine learning based
classifiers for the detection and discrimination of PD, AD and healthy controls (HC).
Features are generated using the scaled subprofile model/principal component analysis
(SSM/PCA) method as in [9]. SSM/PCA is a multivariate method designed to find spatial
covariance patterns in combined samples from patient and control scans [10,11]. Specif-
ically, we look at the performance of Learning Vector Quantization (LVQ) models ver-
sus the more popular and widely used Support Vector Machine (SVM) [12]. In contrast
to SVMs, the models produced by LVQ are interpretable and can deal with multi-class
problems naturally. In particular we look at Generalized Matrix Learning Vector Quanti-
zation (GMLVQ) [13], which extends the LVQ model with an adaptive relevance matrix
in the distance measure that captures the correlations between different features and their
importance for the classification.
The FDG-PET data used in this work is obtained from three different neuroimaging
centers located in Europe. We investigate the classifiers’ ability to discriminate patient
groups when trained from data that was obtained at one specific neuroimaging facility.
It is the ultimate goal to build an universal classifier that performs well regardless of the
center where the data was obtained. Therefore, we study, besides center specific classi-
fication performance, the quality of cross-center classification, i.e., training the systems
on data from one facility and testing its performance with data from a different one. In
addition, we study whether the classifiers can be trained to assign data samples to their
center of origin, to see if any center specific patterns exist in the data. In spite of the fact
that similar technical platforms and supposedly identical processing pipelines have been
used.
The paper is organised as follows: Section 2 includes a brief discussion of the data
acquisition process, feature generation, used classification models and the experiment set
ups. The results and discussion are given in Section 3 with the conclusion in Section 4.
The paper is completed in Section 5 with a description of future work and a discussion
thereof.
2. Data and Methods
In this section we summarize the workflow we followed with respect to data acquisition,
feature extraction, and the validation of the SVMs and GMLVQ models.
2.1. Data Acquisition
In this study we use the brain images acquired using [18F]-fluoro-deoxyglucose positron
emission tomography (FDG-PET), from three different hospitals. The first part is from
the Movement Disorders Unit of the Clinica Universidad de Navarra (CUN), from which
the scans of 19 HC subject and 68 patients diagnosed with PD were included, whose clin-
ical and metabolic data were published in [14]. Secondly, 20 PD patients, 21 AD patients
and 19 HCs were obtained from the University Medical Center Groningen (UMCG),
for whom more details can be found in [15]. Thirdly, we have 58 patients with PD,
55 patients with AD and 44 HCs from the University of Genoa and IRCCS AOU San
Martino-IST (UGOSM). All images were spatially normalized onto an [18F]-FDG-PET
template in Montreal Neurological Institute (MNI) brain space [16], using SPM12 soft-
ware (Wellcome Department of Imaging Neuroscience, Institute of Neurology, London,
UK), implemented in Matlab (version 2017b).
2.2. Feature Extraction
In this step the FDG-PET brain images from the three different centers were used. Fea-
tures were extracted based on an implementation described in [9,17,18,19], which uses
the SSM/PCA method as introduced by Spetsieris and Eidelberg [10]. SSM/PCA was de-
veloped as a way of dealing with the typically high dimensional datasets, that are found
in imaging experiments, as well as the variability in brain activity between subjects and
regions [11].
The initial step requires the images to be spatially normalized and flattened. The
image data is then masked to reduce the number of low values and noise. The mask
has been obtained by putting image data from a disjoint group of patients through the
SSM/PCA process to obtain the disease related patterns. For instance, the FDG-PET
data of HC subjects and disease specific patients specifically PD and AD, results in two
disease related patterns, i.e., PDRP and ADRP. These patterns are considered to be true
descriptors of the abnormal regional interactions due to the invariability and specificity
of the disease-related patterns and can therefore be applied to other centers as well. For
this work we have looked at the effect of applying the two different masks separately and
their combination, which is done by concatenating the subject scores, and have found no
significant difference in performance.
The features, i.e. the subject scores are obtained by applying a log-transform and
centering the data, for details see Spetsieris and Eidelberg [10]. The difference between
the implementation described in [9,17,18,19] and the method used here is in the compu-
tation of the subject scores. The subject scores are computed by projecting (inner prod-
uct) the processed data onto the disease specific GIS (Group Invariant Subprofile) matrix
which is, in contrast to the aforementioned work, obtained not from the training set, but
from the same disjoint patient groups that were used to acquire the masks. The final pro-
jected subject scores will have a dimensionality equal to the number of subjects in the
disjoint group, which contains 36 patients in our case.
2.3. Models and Validation
The subject scores, as described in the previous section, are used to train the classi-
fiers. We consider two specific frameworks for classification: the Support Vector Ma-
chine (SVM) and the LVQ variant Generalised Matrix Learning Vector Quantization
(GMLVQ).
The SVM is a popular binary classification method introduced in [12,20]. SVMs
try to find the maximum margin separation between two hyperplanes, employing the so-
called kernel trick for non separable data, see for example [21] for more detail. In this
study we have used a SVM with a linear kernel. In particular, we employed the Matlab
R2018a (Statistics Toolbox) functions ”fitcsvm” and ”predict” with default settings, for
training and testing, respectively.
Generalized Matrix LVQ was introduced by Schneider et al. [13], and extends
the distance measure with an adaptive relevance matrix which defines a generalized
quadratic distance measure. In particular, its diagonal elements can be interpreted as a
quantification of the relevance of the respective feature dimensions for the classification
[13,22,23]. The LVQ models try to find the prototypical representation of a category or
class of data. These prototypes together with the relevance matrix, allow GMLVQ to ac-
count for correlations between features, resulting in a robust performing and interpretable
model [13,24]. In our work we used both the global relevance (GMLVQ) and the local
variant (LGMLVQ). The local variant attaches a relevance matrix to every class in con-
trast to the single matrix of the global variant. Besides a potentially better performance,
LGMLVQ also provides insight into which features are important per disease. For ap-
plying (L)GMLVQ, we resorted to the publicly available toolbox provided at [25]. The
relevance matrix, or matrices in the case of LGMLVQ, were initialized with the identity
matrix. The regularization parameter [25] was set to 0 and training was performed over
50 epochs of stochastic gradient descent (”sgd”). All other parameters were left at their
default values, see [25].
Unless otherwise specified, for each of the considered classification problems, per-
formance was estimated by averaging 10 randomized realizations of 10 fold-cross val-
idation, see Section 3 for the results. For every fold a z-score transform was applied
based on the subject scores selected for training. As performance measures, we consid-
ered sensitivity and specificity of the unbiased SVM and Nearest Prototype (L)GMLVQ
classifier, as well as the areas under the ROC curve (AUC).
3. Results
In this section we present the results of the classifiers’ ability to discriminate between
the different patient groups, when trained on data from a specific center. In addition, we
looked at the performance of cross-center classification, i.e., the models are trained on
the data from one facility and tested on another. Lastly, we have included the results of
the experiments where we train the models to distinguish between the center of origin,
using only one group, e.g., only HC or only PD patients.
Lastly, we have included the results that show that, from both the disease specific
and healthy control data, it is possible to identify nearly perfectly the center the data has
been obtained.
Classifier Sens. (%) Spec. (%) AUC
HC vs. PD SVM 74.23(18.98) 68.05(25.90) 0.80(0.16)
GMLVQ 75.13(16.93) 77.50(22.45) 0.84(0.11)
LGMLVQ 79.23(15.23) 68.15(22.55) 0.83(0.12)
HC vs. AD SVM 95.40(8.86) 92.00(13.10) 0.99(0.03)
GMLVQ 88.67(15.02) 92.90(13.37) 0.97(0.06)
LGMLVQ 91.47(12.26) 91.45(14.40) 0.98(0.04)
PD vs. AD SVM 82.10(16.18) 83.83(15.99) 0.92(0.07)
GMLVQ 81.00(17.22) 81.67(15.82) 0.91(0.09)
LGMLVQ 84.70(15.24) 86.63(14.77) 0.95(0.06)
Table 1. Data provided by UGOSM. Performance of three different models: SVM, GMLVQ, and LGMLVQ
on three different classification problems. During pre-processing the PDRP was used to mask the data. Average
values are shown together with standard deviations (in brackets).
3.1. Center specific classification
Our experiments confirm that the prime objective to discriminate between condition (HC,
PD, AD) can be achieved to good accuracy when classifiers are trained from (and ap-
plied to) center specific data. As a representative example of the achievable performance
on center specific data, Table 1 displays the results for the three different binary clas-
sification problems (HC/PD, HC/AD, AD/PD) with respect to the data from UGOSM.
Results can vary slightly when applying the different masks before the feature extrac-
tion, but no significant difference was found. All reported results are from applying the
PD specific mask. These results are comparable or slightly better than the ones found in
[9,17,18,19] although a direct numerical comparison is not possible due to differences in
feature extraction, model validation and data sets.
Table 1 shows that there is no significant difference among the performance of the
(L)GMLVQ and SVM classifiers. All three classifiers produce good (0.80) to near perfect
AUCs (0.99). The observed differences can be explained by potentially suboptimal hyper
parameters. A benefit of (L)GMLVQ is that it can deal with multi-class classification
naturally and it is interpretable (see [23]), in contrast to the SVM. With (L)GMLVQ we
could approach the ternary problem (of distinguishing between HC, AD, and PD) in a
more straightforward way, which the SVM could not deal with without the need of binary
combination schemes. We did not include other than binary classification results to keep
the comparison with the SVM. Due to the interpretable nature of (L)GMLVQ we could
gain further insight into the diseases themselves, i.e., which features are more important
for one disease and which are for another, and how does that compare to the relevance
profile of the healthy subjects.
3.2. Cross-center classification
The results of three cross center models are shown in Table 2. The table includes the
results for the HC versus PD classification problem as representative example. We see
that the performances relative to the center specific performances have decreased con-
siderably, suggesting different patterns in the data from the centers. These differences
could be due to technical equipment or pre-processing pipelines which may differ in de-
tails from center to center. Consequently, we do not have the ideal conditions that we in-
Classifier Sens. (%) Spec. (%) AUC
Train: CUN SVM 58.62 70.45 0.68
Test: UGOSM GMLVQ 86.21 31.82 0.72
LGMLVQ 98.28 4.55 0.57
Train: UGOSM SVM 100.00 21.05 0.82
Test: UMCG GMLVQ 70.00 63.16 0.74
LGMLVQ 95.00 47.37 0.91
Train: UMCG SVM 54.41 73.68 0.70
Test: CUN GMLVQ 33.82 89.47 0.70
LGMLVQ 47.06 84.21 0.72
Table 2. Performance of the three models for the HC versus PD classification problem. The models were
trained on the data of one center and tested on a different center. The PDRP was used to mask the data during
pre-processing.

































































Figure 1. Comparison among the prototypes obtained when classify HC (top blue) and PD (bottom red) from
each center, using GMLVQ.
tended in our objectives to build a universal classifier capable of classifying any subject
from any center. In [9] a similar decrease in performance was found between the center
specific classification and training and testing using data from different centers.
The prototypes, shown in Fig. 1 confirm this finding. The plots include the proto-
types between HC and PD, and we see that the classifiers build different profiles for the
same classes depending on the origin of the samples, i.e., CUN, UMCG or UGOSM.
This is a sign that the data of the centers are different and could indirectly explain why
we can differentiate so easily the center of origin, as each center has different features to
characterize the same disease. This is reflected in both the disease (Table 3) as well as
the healthy control data (Table 4).
Additionally, in Fig. 2, we can see how the relevance profile, provided by GMLVQ,
varies for each center. Thus, for each center different discriminative features are most



























Figure 2. Comparison among the diagonal of relevance matrices obtained when classifying HC (class 1) and
PD (class 2) from each center, using GMLVQ.
Classifier Sens. (%) Spec. (%) AUC
CUN vs. UGOSM SVM 88.60(12.98) 89.69(10.16) 0.96(0.04)
GMLVQ 89.77(13.07) 92.81(8.85) 0.98(0.04)
LGMLVQ 92.60(10.87) 94.12(8.97) 0.99(0.03)
UGOSM vs. UMCG SVM 97.27(8.24) 87.50(26.94) 0.99(0.04)
GMLVQ 91.83(11.87) 80.00(26.59) 0.94(0.12)
LGMLVQ 97.80(5.73) 71.00(32.71) 0.92(0.14)
UMCG vs. CUN SVM 82.50(26.94) 98.21(4.87) 0.99(0.03)
GMLVQ 89.00(20.82) 99.83(1.67) 1.00(0.02)
LGMLVQ 84.00(24.49) 100.00(0.00) 0.96(0.10)
Table 3. Data are from the PD patients from the two centers in the context of the problem. The PDRP was
used to mask the data during pre-processing. Average values are shown together with standard deviations (in
brackets).
Classifier Sens. (%) Spec. (%) AUC
CUN vs. UGOSM SVM 99.75(2.50) 93.00(21.34) 1.00(0.01)
GMLVQ 97.30(7.40) 91.00(21.77) 0.99(0.04)
LGMLVQ 100.00(0.00) 89.50(24.92) 0.99(0.06)
UGOSM vs. UMCG SVM 97.75(6.83) 87.50(25.99) 0.97(0.08)
GMLVQ 92.75(12.50) 81.00(28.23) 0.95(0.12)
LGMLVQ 98.85(5.07) 70.00(32.57) 0.95(0.10)
UMCG vs. CUN SVM 95.50(14.38) 100.00(0.00) 100.00(0.00)
GMLVQ 100.00(0.00) 100.00(0.00) 100.00(0.00)
LGMLVQ 100.00(0.00) 99.50(5.00) 100.00(0.00)
Table 4. Data are from the healthy controls from the two centers in the context of the problem. The PDRP was
used to mask the data during pre-processing. Average values are shown together with standard deviations (in
brackets).
discriminative in the classification, which should be related to the fact that the centers
end up being so distinguishable.
The results shown in Table 3 and 4 show the performance achieved classifying the
different centers from both the PD data of HC data. Evidently, the difference between im-
ages from one center versus another are present, with near perfect AUC scores for almost
all models. The fact that this can be observed in the HC data supports the assumption
that the center specific properties are caused by a difference in protocols or equipment.
4. Conclusions
We have demonstrated that it is feasible to achieve reliable diagnosis and discrimination
of neurodegenerative diseases from FDG-PET scans based on SSM/PCA features. How-
ever, performance deteriorates in cross-center classification. Our results show that the
datasets display center specific properties which may hinder the development of a univer-
sally applicable classifier. Therefore, a more unified approach should be aimed at when
pre-processing and normalizing the data, achieving greater homogeneity with respect to
measurements, calibration and processing protocols.
5. Future Work
In future work we will focus on further optimizing the used models as well as investi-
gating the specific differences between the centers. In the best case, all data comes from
sources using identical equipment and procedures. This is however not a practical re-
quirement for a universally applicable classifier. One idea is to identify the specific dif-
ferences in patterns between the centers which can potentially lead to another normaliza-
tion step to cancel out the center specific artifacts. In forthcoming projects, we will focus
on the identification of the specific patterns by, e.g., using the interpretable (L)GMLVQ
models. Although these models are interpretable the SSM/PCA features they are trained
on are not directly. Therefore, we will propose a visualization of prototypes and rele-
vance profiles in voxel space. This can be done by exploiting the linearity of the trans-
formations as applied during the feature extraction step, on the prototypes and relevance
matrices. Example applications of this concept in different data domains can be found in
[26,27].
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